ABSTRACT
Objective Alternating Hemiplegia of Childhood (AHC) is characterised by paroxysmal hemiplegic episodes and seizures. Remission of hemiplegia upon sleep is a clinical diagnostic feature of AHC. We investigated whether: 1) Hemiplegic events are associated with spectral EEG changes 2) Sleep in AHC is associated with clinical or EEG spectral features that may explain its restorative effect.
Methods We retrospectively performed EEG spectral analysis in five adults with AHC and twelve age-/gender-matched epilepsy controls. Five-minute epochs of hemiplegic episodes and ten-minute epochs of four sleep stages were selected from video-EEGs. Arousals were counted per hour of sleep.
Results We found 1) hemispheric differences in pre-ictal and ictal spectral power (p=0.034), during AHC hemiplegic episodes 2) 22% reduced beta power (p=0.017) and 26% increased delta power (p=0.025) during wakefulness in AHC versus controls. There were 98% more arousals in the AHC group versus controls (p=0.0003).
Conclusions There are hemispheric differences in spectral power preceding hemiplegic episodes in adults with AHC, and sleep is disrupted.
Significance Spectral EEG changes may be a potential predictive tool for AHC hemiplegic episodes. Significantly disrupted sleep is a feature of AHC and is of particular importance when considering risk of sudden unexpected death in epilepsy (SUDEP).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval was granted by UCLH research ethics committee (11/LO/2016) and either informed consent, or assent given by parents or legal guardians, was obtained.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations of Interest: None.
Data Availability
Data cannot be shared publicly because it is patient data protected by the Data Protection Act. Data are available from UCL Data Access (contact via the corresponding author) for researchers who meet the criteria for access to confidential data.
